Prime Medicine, Inc. (NYSE:PRME) Given Consensus Rating of “Moderate Buy” by Analysts
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month […]
More Stories
Why 3D Configurators Are Shaping the Future of Luxury Furniture Brands
Success in the luxury industry increasingly depends on delivering personalization, visual engagement, and streamlined buying experiences—and the furniture sector is...
Two Sigma Advisers LP Acquires 20,500 Shares of Highwoods Properties, Inc. (NYSE:HIW)
Two Sigma Advisers LP lifted its holdings in shares of Highwoods Properties, Inc. (NYSE:HIW – Free Report) by 31.2% during...
ProShare Advisors LLC Boosts Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)
ProShare Advisors LLC boosted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 44.4% during...
Tidal Investments LLC Sells 15,374 Shares of International Seaways, Inc. (NYSE:INSW)
Tidal Investments LLC reduced its holdings in shares of International Seaways, Inc. (NYSE:INSW – Free Report) by 46.1% in the...
Boise Cascade (NYSE:BCC) Shares Bought by Two Sigma Advisers LP
Two Sigma Advisers LP raised its position in shares of Boise Cascade (NYSE:BCC – Free Report) by 22.8% in the...
Two Sigma Advisers LP Raises Holdings in Hilltop Holdings Inc. (NYSE:HTH)
Two Sigma Advisers LP boosted its stake in Hilltop Holdings Inc. (NYSE:HTH – Free Report) by 23.8% during the fourth...